{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074231","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.278581+00:00","generated_at":"2026-06-01T04:02:40.421515+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Agenus appoints Jennifer Buell to Board of Directors, stresses BOT/BAL BLA filing","bullets":["Dr. Jennifer Buell appointed to Agenus Board effective June 11, 2024.","Buell remains President/CEO of MiNK Therapeutics and Chairman of Agenus Executive Council.","Priority is to guide BOT/BAL program toward Biologics License Application submission this year.","Brings 27+ years biopharma experience; previously served as President & COO of Agenus.","No committee assignments; previously granted options for 37,500 shares (2023 and 2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074231","json":"https://secwatch.observer/filing/0000950170-24-074231.json","markdown":"https://secwatch.observer/filing/0000950170-24-074231.md","text":"https://secwatch.observer/filing/0000950170-24-074231.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/0000950170-24-074231-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/agen-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:02:40.421515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae6cde1fa0","claim":"Jennifer Buell was appointed as Director at AGENUS INC.","evidence_excerpt":"Dr. Jennifer Buell was appointed to the Board of Directors of Agenus Inc. (Agenus) on June 11, 2024, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024074231/0000950170-24-074231-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}